NVCT

Nuvectis Pharma Inc. Common Stock (NVCT)

Stock · NASDAQ · Health Care

$23.73as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$8.3
Industry
Biotechnology: Pharmaceutical Preparations

Nuvectis Pharma Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • NVCT
    Nuvectis Pharma Inc. Common Stock
    $23.73
    ▼ 5.80%
    Market cap $613.51MP/E
  • CBIO
    Crescent Biopharma Inc. Common Stock
    $17.74
    ▼ 0.14%
    Market cap $610.27MP/E
    $8.72$27.41
  • MPLT
    MapLight Therapeutics Inc. Common Stock
    $12.64
    ▲ 0.80%
    Market cap $602.19MP/E
    $9.1$40.43
  • CRMD
    CorMedix Inc. Common Stock
    $8.31
    ▼ 0.06%
    Market cap $589.17MP/E 3.53
    $6.13$14.96
  • ARVN
    Arvinas Inc. Common Stock
    $9.16
    ▼ 0.87%
    Market cap $567.55MP/E 62.96
    $6.97$14.51
  • NGNE
    Neurogene Inc. Common Stock
    $36.38
    ▼ 3.91%
    Market cap $680.52MP/E
  • SGMT
    Sagimet Biosciences Inc. Series A Common Stock
    $10.55
    ▼ 1.86%
    Market cap $539.71MP/E
    $4.5$11.15

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
4.26M
Total value held
$32.84M
Institutional holders
58
Top holders this quarter
  • Unknown764.4K
  • Unknown659.9K
  • Unknown651.8K
  • Unknown407.1K
  • Unknown384.1K
  • Unknown378.6K
  • Unknown166.5K
  • Unknown124.2K
  • Unknown105.3K
  • Unknown78.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.